Legal analysis: 1. Category A drugs. Drugs that are necessary for clinical treatment, widely used, efficacious, and low-priced in their category. When participants use this kind of drugs, they can be fully included in the scope of reimbursement and reimbursed at the prescribed rate.
2. Category B drugs. Clinical treatment options for use, therapeutic efficacy, in the same category of drugs than the price of drugs in Category A drugs. When a participant uses a Class B drug, a certain amount of personal out-of-pocket expenses will be deducted according to the proportion (set by each region), and then the remaining expenses will be included in the scope of reimbursement and reimbursed according to the prescribed proportion.
3. Class C drugs. Not covered by basic medical care, most areas require 100% personal out-of-pocket payment. Of course, some areas may also be reimbursed some of the specific can look at the hospital invoice on the "self-care ratio" column. The C drugs generally include: health care products, high-grade drugs, newly developed drugs, anti-cancer imported drugs and so on.
Legal basis: "Medical Security Law (Draft)" Article 31 The state establishes a centralized purchasing system for medicines and medical supplies for public medical institutions. The administrative department of medical security formulates bidding and purchasing policies for drugs and medical consumables and supervises their implementation, guiding the construction of centralized purchasing platforms for drugs and medical consumables.